Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Abroad (travel likely)RecruitingPHASE3
Conditions
Stage II-III Non-small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shanghai Chest Hospital, Shanghai, China
Study leads
Xuwei Cai
Principal Investigator
Department of Radiation Oncology， Shanghai Chest Hospital, Shanghai, China
Zhigang Li
Principal Investigator
Department of Thoracic Surgery， Shanghai Chest Hospital, Shanghai, China
Songbing Qin
Principal Investigator
Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China